• 2019
  Grieder TE, Besson M, Maal-Bared G, Pons S, Maskos U, van der Kooy D, β2* nAChRs on VTA dopamine and GABA neurons separately mediate nicotine aversion and reward, Proc. Natl. Acad. Sci. U.S.A. 2019 Nov;.
• 2019
  Zhang XM, François U, Silm K, Angelo MF, Fernandez-Busch MV, Maged M, Martin C, Bernard V, Cordelières FP, Deshors M, Pons S, Maskos U, Bemelmans AP, Wojcik SM, El Mestikawy S, Humeau Y, Herzog E, A proline-rich motif on VGLUT1 reduces synaptic vesicle super-pool and spontaneous release frequency, Elife 2019 Oct;8.
• 2019
  Besson M, Forget B, Correia C, Blanco R, Maskos U, Profound alteration in reward processing due to a human polymorphism in CHRNA5: a role in alcohol dependence and feeding behavior, Neuropsychopharmacology 2019 Jul;.
• 2019
  Besson M, Forget B, Correia C, Blanco R, Maskos U., Profound alteration in reward processing due to a human polymorphism in CHRNA5: a role in alcohol dependence and feeding behavior, Neuropsychopharmacology. doi: 10.1038/s41386-019-0462-0. [Epub ahead of print].
• 2018
  Esmaeilzade B, Artimani T, Amiri I, Najafi R, Shahidi S, Sabec M, Farzadinia P, Zare M, Zahiri M, Soleimani Asl S, Dimethyloxalylglycine preconditioning enhances protective effects of bone marrow-derived mesenchymal stem cells in Aβ- induced Alzheimer disease, Physiol. Behav. 2019 02;199:265-272.
• 2018
  Forget B, Scholze P, Langa F, Morel C, Pons S, Mondoloni S, Besson M, Durand-de Cuttoli R, Hay A, Tricoire L, Lambolez B, Mourot A, Faure P, Maskos U, A Human Polymorphism in CHRNA5 Is Linked to Relapse to Nicotine Seeking in Transgenic Rats, Curr. Biol. 2018 Oct;28(20):3244-3253.e7.
• 2018
  Durand-de Cuttoli R, Mondoloni S, Marti F, Lemoine D, Nguyen C, Naudé J, d'Izarny-Gargas T, Pons S, Maskos U, Trauner D, Kramer RH, Faure P, Mourot A, Manipulating midbrain dopamine neurons and reward-related behaviors with light-controllable nicotinic acetylcholine receptors, Elife 2018 Sep;7.
• 2018
  Vitrac A, Cloëz-Tayarani I, Induced pluripotent stem cells as a tool to study brain circuits in autism-related disorders, Stem Cell Res Ther 2018 Aug;9(1):226.
• 2018
  Icick R, Vorspan F, Karsinti E, Ksouda K, Lépine JP, Brousse G, Mouly S, Bellivier F, Bloch V, Gender-specific study of recurrent suicide attempts in outpatients with multiple substance use disorders, J Affect Disord 2018 12;241:546-553.
• 2018
  Uspenska K, Lykhmus O, Obolenskaya M, Pons S, Maskos U, Komisarenko S, Skok M, Mitochondrial Nicotinic Acetylcholine Receptors Support Liver Cells Viability After Partial Hepatectomy, Front Pharmacol 2018;9:626.
• 2018
  Collo G, Cavalleri L, Zoli M, Maskos U, Ratti E, Merlo Pich E, Alpha6-Containing Nicotinic Acetylcholine Receptors Mediate Nicotine-Induced Structural Plasticity in Mouse and Human iPSC-Derived Dopaminergic Neurons, Front Pharmacol 2018;9:572.
• 2018
  Uspenska K, Lykhmus O, Arias HR, Pons S, Maskos U, Komisarenko S, Skok M, Positive allosteric modulators of α7* or β2* nicotinic acetylcholine receptors trigger different kinase pathways in mitochondria, Int. J. Biochem. Cell Biol. 2018 Apr;.
• 2018
  Karsinti E, Piani K, Zerdazi EH, Maskos U, Faure P, Romo L, Bellivier F, Brousse G, Lépine JP, Bloch V, Vorspan F, Relevance of treated cocaine users’ retrospective memory of first cocaine use, Psychiatry Res 2018 Mar;264:210-216.
• 2018
  Sabec MH, Wonnacott S, Warburton EC, Bashir ZI, Nicotinic Acetylcholine Receptors Control Encoding and Retrieval of Associative Recognition Memory through Plasticity in the Medial Prefrontal Cortex, Cell Rep 2018 Mar;22(13):3409-3415.
• 2017
  Morel C, Fernandez SP, Pantouli F, Meye FJ, Marti F, Tolu S, Parnaudeau S, Marie H, Tronche F, Maskos U, Moretti M, Gotti C, Han MH, Bailey A, Mameli M, Barik J, Faure P, Nicotinic receptors mediate stress-nicotine detrimental interplay via dopamine cells’ activity, Mol. Psychiatry 2017 Jul;.
• 2017
  Benamer N, Marti F, Lujan R, Hepp R, Aubier TG, Dupin AAM, Frébourg G, Pons S, Maskos U, Faure P, Hay YA, Lambolez B, Tricoire L, GluD1, linked to schizophrenia, controls the burst firing of dopamine neurons, Mol. Psychiatry 2017 Jul;.
• 2017
  Campagne C, Pons S, Esquerre D, Estellé J, Bourneuf E, Maskos U, Egidy G, Transcriptome of melanoma cells from two mouse models, Tyr:NRas(Q61K) and Tyr:Rack1-HA, Tyr:NRas(Q61K), Data Brief 2017 Oct;14:32-34.
• 2017
  Campagne C, Reyes-Gomez E, Picco ME, Loiodice S, Salaun P, Ezagal J, Bernex F, Commère PH, Pons S, Esquerre D, Bourneuf E, Estellé J, Maskos U, Lopez-Bergami P, Aubin-Houzelstein G, Panthier JJ, Egidy G, RACK1 cooperates with NRAS(Q61K) to promote melanoma in vivo, Cell. Signal. 2017 Aug;36:255-266.
• 2016
  Koukouli F, Rooy M, Maskos U, Early and progressive deficit of neuronal activity patterns in a model of local amyloid pathology in mouse prefrontal cortex, 2016 Dec 20;8(12):3430-3449. .
• 2016
  Koukouli F, Rooy M, Changeux JP, Maskos U, Nicotinic receptors in mouse prefrontal cortex modulate ultraslow fluctuations related to conscious processing., 2016 Dec 20;113(51):14823-14828..
• 2016
  Deflorio C, Blanchard S, Carisì MC, Bohl D, Maskos U, Human polymorphisms in nicotinic receptors: a functional analysis in iPS-derived dopaminergic neurons, FASEB J. 2017 02;31(2):828-839.
• 2016
  Li T, Vandesquille M, Koukouli F, Dudeffant C, Youssef I, Lenormand P, Ganneau C, Maskos U, Czech C, Grueninger F, Duyckaerts C, Dhenain M, Bay S, Delatour B, Lafaye P, Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets, J Control Release 2016 Dec;243:1-10.
• 2016
  Mercati O, Huguet G, Danckaert A, André-Leroux G, Maruani A, Bellinzoni M, Rolland T, Gouder L, Mathieu A, Buratti J, Amsellem F, Benabou M, Van-Gils J, Beggiato A, Konyukh M, Bourgeois JP, Gazzellone MJ, Yuen RK, Walker S, Delépine M, Boland A, Régnault B, Francois M, Van Den Abbeele T, Mosca-Boidron AL, Faivre L, Shimoda Y, Watanabe K, Bonneau D, Rastam M, Leboyer M, Scherer SW, Gillberg C, Delorme R, Cloëz-Tayarani I, Bourgeron T, CNTN6 mutations are risk factors for abnormal auditory sensory perception in autism spectrum disorders, Mol. Psychiatry 2017 04;22(4):625-633.
• 2016
  Naudé J, Tolu S, Dongelmans M, Torquet N, Valverde S, Rodriguez G, Pons S, Maskos U, Mourot A, Marti F, Faure P, Nicotinic receptors in the ventral tegmental area promote uncertainty-seeking, Nat. Neurosci. 2016 Jan;.
• 2015
  Harrington L, Viñals X, Herrera-Solís A, Flores A, Morel C, Tolu S, Faure P, Maldonado R, Maskos U, Robledo P, Role of β4* Nicotinic Acetylcholine Receptors in the Habenulo-Interpeduncular Pathway in Nicotine Reinforcement in Mice, Neuropsychopharmacology 2015 Nov;.
• 2015
  Gouder L, Tinevez JY, Goubran-Botros H, Benchoua A, Bourgeron T, Cloëz-Tayarani I, Three-dimensional Quantification of Dendritic Spines from Pyramidal Neurons Derived from Human Induced Pluripotent Stem Cells, J Vis Exp 2015 Oct;(104).
• 2015
  M. Vandesquille, T. Li, F. Koukouli, C. Ganneau, U. Maskos, C. Czech, F. Grueninger, C. Duyckaerts, B. Delatour, S. Bay, P. Lafaye, M. Dhenain, New tools for amyloid plaques detection by MRI: Gadolinium-VHH antibody conjugates, 2014; 10, Supplement, P14–P15.
• 2015
  Koukouli F, Maskos U, The multiple roles of the α7 nicotinic acetylcholine receptor in modulating glutamatergic systems in the normal and diseased nervous system, Biochem. Pharmacol. 2015 Oct;97(4):378-87.
• 2015
  Wieskopf JS, Mathur J, Limapichat W, Post MR, Al-Qazzaz M, Sorge RE, Martin LJ, Zaykin DV, Smith SB, Freitas K, Austin JS, Dai F, Zhang J, Marcovitz J, Tuttle AH, Slepian PM, Clarke S, Drenan RM, Janes J, Al Sharari S, Segall SK, Aasvang EK, Lai W, Bittner R, Richards CI, Slade GD, Kehlet H, Walker J, Maskos U, Changeux JP, Devor M, Maixner W, Diatchenko L, Belfer I, Dougherty DA, Su AI, Lummis SC, Imad Damaj M, Lester HA, Patapoutian A, Mogil JS, The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptors, Sci Transl Med 2015 May;7(287):287ra72.
• 2015
  Khayati F, Pérez-Cano L, Maouche K, Sadoux A, Boutalbi Z, Podgorniak MP, Maskos U, Setterblad N, Janin A, Calvo F, Lebbé C, Menashi S, Fernandez-Recio J, Mourah S, EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF, Oncotarget 2015 Apr;6(12):9766-80.
• 2015
  Sciaccaluga M, Moriconi C, Martinello K, Catalano M, Bermudez I, Stitzel JA, Maskos U, Fucile S, Crucial role of nicotinic α5 subunit variants for Ca2+ fluxes in ventral midbrain neurons, FASEB J. 2015 Apr;.
• 2015
  Delyon J, Khayati F, Djaafri I, Podgorniak MP, Sadoux A, Setterblad N, Boutalbi Z, Maouche K, Maskos U, Menashi S, Lebbé C, Mourah S, EMMPRIN regulates β1 integrin-mediated adhesion through Kindlin-3 in human melanoma cells, Exp. Dermatol. 2015 Jun;24(6):443-8.
• 2015
  Changeux JP, Corringer PJ, Maskos U, The nicotinic acetylcholine receptor: From molecular biology to cognition, Neuropharmacology 2015 Sep;96(Pt B):135-6.
• 2014
  Lombardo S, Maskos U, Role of the nicotinic acetylcholine receptor in Alzheimer’s disease pathology and treatment, Neuropharmacology 2015 Sep;96(Pt B):255-62.
• 2014
  Muldoon PP, Jackson KJ, Perez E, Harenza JL, Molas S, Rais B, Anwar H, Zaveri NT, Maldonado R, Maskos U, McIntosh JM, Dierssen M, Miles MF, Chen X, De Biasi M, Damaj MI, The α3β4* nicotinic ACh receptor subtype mediates physical dependence to morphine: mouse and human studies, Br. J. Pharmacol. 2014 Aug;171(16):3845-57.
• 2014
  Sanjakdar SS, Maldoon PP, Marks MJ, Brunzell DH, Maskos U, McIntosh JM, Bowers MS, Damaj MI, Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice, Neuropsychopharmacology 2015 Jan;40(2):350-60.
• 2014
  Moretti M, Zoli M, George AA, Lukas RJ, Pistillo F, Maskos U, Whiteaker P, Gotti C, The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization, Mol. Pharmacol. 2014 Sep;86(3):306-17.
• 2014
  Somm E, Guérardel A, Maouche K, Toulotte A, Veyrat-Durebex C, Rohner-Jeanrenaud F, Maskos U, Hüppi PS, Schwitzgebel VM, Concomitant alpha7 and beta2 nicotinic AChR subunit deficiency leads to impaired energy homeostasis and increased physical activity in mice, Mol. Genet. Metab. 2014 May;112(1):64-72.
• 2013
  Morel C, Fattore L, Pons S, Hay YA, Marti F, Lambolez B, De Biasi M, Lathrop M, Fratta W, Maskos U, Faure P, Nicotine consumption is regulated by a human polymorphism in dopamine neurons, Mol. Psychiatry 2014 Aug;19(8):930-6.
• 2013
  Valley MT, Henderson LG, Inverso SA, Lledo PM, Adult neurogenesis produces neurons with unique GABAergic synapses in the olfactory bulb, J. Neurosci. 2013 Sep;33(37):14660-5.
• 2013
  Collo G, Bono F, Cavalleri L, Plebani L, Mitola S, Merlo Pich E, Millan MJ, Zoli M, Maskos U, Spano P, Missale C, Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine D3 receptors and Akt-mTORC1 signaling, Mol. Pharmacol. 2013 Jun;83(6):1176-89.
• 2013
  Maouche K, Medjber K, Zahm JM, Delavoie F, Terryn C, Coraux C, Pons S, Cloëz-Tayarani I, Maskos U, Birembaut P, Tournier JM, Contribution of α7 nicotinic receptor to airway epithelium dysfunction under nicotine exposure, Proc. Natl. Acad. Sci. U.S.A. 2013 Mar;110(10):4099-104.
• 2013
  Mercati O, Danckaert A, André-Leroux G, Bellinzoni M, Gouder L, Watanabe K, Shimoda Y, Grailhe R, De Chaumont F, Bourgeron T, Cloëz-Tayarani I, Contactin 4, -5 and -6 differentially regulate neuritogenesis while they display identical PTPRG binding sites, Biol Open 2013 Mar;2(3):324-34.
• 2012
  Mohebiany AN, Nikolaienko RM, Bouyain S, Harroch S, Receptor-type tyrosine phosphatase ligands: looking for the needle in the haystack, FEBS J. 2013 Jan;280(2):388-400.
• 2012
  Tolu S, Eddine R, Marti F, David V, Graupner M, Pons S, Baudonnat M, Husson M, Besson M, Reperant C, Zemdegs J, Pagès C, Hay YA, Lambolez B, Caboche J, Gutkin B, Gardier AM, Changeux JP, Faure P, Maskos U, Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement, Mol. Psychiatry 2013 Mar;18(3):382-93.
• 2012
  Orejarena MJ, Herrera-Solís A, Pons S, Maskos U, Maldonado R, Robledo P, Selective re-expression of β2 nicotinic acetylcholine receptor subunits in the ventral tegmental area of the mouse restores intravenous nicotine self-administration, Neuropharmacology 2012 Aug;63(2):235-41.
• 2012
  Exley R, McIntosh JM, Marks MJ, Maskos U, Cragg SJ, Striatal α5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum, J. Neurosci. 2012 Feb;32(7):2352-6.
• 2011
  Guillem K, Bloem B, Poorthuis RB, Loos M, Smit AB, Maskos U, Spijker S, Mansvelder HD, Nicotinic acetylcholine receptor β2 subunits in the medial prefrontal cortex control attention, Science 2011 Aug;333(6044):888-91.
• 2011
  Bourgeois JP, Meas-Yeadid V, Lesourd AM, Faure P, Pons S, Maskos U, Changeux JP, Olivo-Marin JC, Granon S, Modulation of the mouse prefrontal cortex activation by neuronal nicotinic receptors during novelty exploration but not by exploration of a familiar environment, Cereb. Cortex 2012 May;22(5):1007-15.
• 2011
  Marti F, Arib O, Morel C, Dufresne V, Maskos U, Corringer PJ, de Beaurepaire R, Faure P, Smoke extracts and nicotine, but not tobacco extracts, potentiate firing and burst activity of ventral tegmental area dopaminergic neurons in mice, Neuropsychopharmacology 2011 Oct;36(11):2244-57.
• 2011
  Frahm S, Slimak MA, Ferrarese L, Santos-Torres J, Antolin-Fontes B, Auer S, Filkin S, Pons S, Fontaine JF, Tsetlin V, Maskos U, Ibañez-Tallon I, Aversion to nicotine is regulated by the balanced activity of β4 and α5 nicotinic receptor subunits in the medial habenula, Neuron 2011 May;70(3):522-35.
• 2011
  Toulorge D, Guerreiro S, Hild A, Maskos U, Hirsch EC, Michel PP, Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+, FASEB J. 2011 Aug;25(8):2563-73.
• 2011
  Exley R, Maubourguet N, David V, Eddine R, Evrard A, Pons S, Marti F, Threlfell S, Cazala P, McIntosh JM, Changeux JP, Maskos U, Cragg SJ, Faure P, Distinct contributions of nicotinic acetylcholine receptor subunit alpha4 and subunit alpha6 to the reinforcing effects of nicotine, Proc. Natl. Acad. Sci. U.S.A. 2011 May;108(18):7577-82.
• 2011
  Avale ME, Chabout J, Pons S, Serreau P, De Chaumont F, Olivo-Marin JC, Bourgeois JP, Maskos U, Changeux JP, Granon S, Prefrontal nicotinic receptors control novel social interaction between mice, FASEB J. 2011 Jul;25(7):2145-55.
• 2011
  Lykhmus O, Koval L, Skok M, Zouridakis M, Zisimopoulou P, Tzartos S, Tsetlin V, Granon S, Changeux JP, Komisarenko S, Cloëz-Tayarani I, Antibodies against extracellular domains of α4 and α7 subunits alter the levels of nicotinic receptors in the mouse brain and affect memory: possible relevance to Alzheimer’s pathology, J. Alzheimers Dis. 2011;24(4):693-704.
• 2010
  Azam L, Maskos U, Changeux JP, Dowell CD, Christensen S, De Biasi M, McIntosh JM, α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6ß4 and α6ß2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release, FASEB J. 2010 Dec;24(12):5113-23.
• 2010
  Melis M, Carta S, Fattore L, Tolu S, Yasar S, Goldberg SR, Fratta W, Maskos U, Pistis M, Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors, Biol. Psychiatry 2010 Aug;68(3):256-64.
• 2010
  Maskos U, Role of endogenous acetylcholine in the control of the dopaminergic system via nicotinic receptors, J. Neurochem. 2010 Aug;114(3):641-6.
• 2009
  Lykhmus O, Koval L, Pavlovych S, Zouridakis M, Zisimopoulou P, Tzartos S, Tsetlin V, Volpina O, Cloëz-Tayarani I, Komisarenko S, Skok M, Functional effects of antibodies against non-neuronal nicotinic acetylcholine receptors, Immunol. Lett. 2010 Jan;128(1):68-73.
• 2009
  Reperant C, Pons S, Dufour E, Rollema H, Gardier AM, Maskos U, Effect of the alpha4beta2* nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in beta2 knock-out mice with selective re-expression of the beta2 subunit in the ventral tegmental area, Neuropharmacology 2010 Feb;58(2):346-50.
• 2009
  Tolu S, Avale ME, Nakatani H, Pons S, Parnaudeau S, Tronche F, Vogt A, Monyer H, Vogel R, de Chaumont F, Olivo-Marin JC, Changeux JP, Maskos U, A versatile system for the neuronal subtype specific expression of lentiviral vectors, FASEB J. 2010 Mar;24(3):723-30.
• 2008
  Grailhe R, Cardona A, Even N, Seif I, Changeux JP, Cloëz-Tayarani I, Regional changes in the cholinergic system in mice lacking monoamine oxidase A, Brain Res. Bull. 2009 Mar;78(6):283-9.
• 2008
  Maubourguet N, Lesne A, Changeux JP, Maskos U, Faure P, Behavioral sequence analysis reveals a novel role for beta2* nicotinic receptors in exploration, PLoS Comput. Biol. 2008 Nov;4(11):e1000229.
• 2008
  Even N, Cardona A, Soudant M, Corringer PJ, Changeux JP, Cloëz-Tayarani I, Regional differential effects of chronic nicotine on brain alpha 4-containing and alpha 6-containing receptors, Neuroreport 2008 Oct;19(15):1545-50.
• 2008
  Avale ME, Faure P, Pons S, Robledo P, Deltheil T, David DJ, Gardier AM, Maldonado R, Granon S, Changeux JP, Maskos U, Interplay of beta2* nicotinic receptors and dopamine pathways in the control of spontaneous locomotion, Proc. Natl. Acad. Sci. U.S.A. 2008 Oct;105(41):15991-6.
• 2008
  Maskos U, The cholinergic mesopontine tegmentum is a relatively neglected nicotinic master modulator of the dopaminergic system: relevance to drugs of abuse and pathology, Br. J. Pharmacol. 2008 Mar;153 Suppl 1:S438-45.
• 2007
  Zanardi A, Ferrari R, Leo G, Maskos U, Changeux JP, Zoli M, Loss of high-affinity nicotinic receptors increases the vulnerability to excitotoxic lesion and decreases the positive effects of an enriched environment, FASEB J. 2007 Dec;21(14):4028-37.
• 2007
  Moser N, Mechawar N, Jones I, Gochberg-Sarver A, Orr-Urtreger A, Plomann M, Salas R, Molles B, Marubio L, Roth U, Maskos U, Winzer-Serhan U, Bourgeois JP, Le Sourd AM, De Biasi M, Schröder H, Lindstrom J, Maelicke A, Changeux JP, Wevers A, Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures, J. Neurochem. 2007 Jul;102(2):479-92.
• 2007
  Maskos U, Emerging concepts: novel integration of in vivo approaches to localize the function of nicotinic receptors, J. Neurochem. 2007 Feb;100(3):596-602.
• 2006
  Cloëz-Tayarani I, Changeux JP, Nicotine and serotonin in immune regulation and inflammatory processes: a perspective, J. Leukoc. Biol. 2007 Mar;81(3):599-606.
• 2006
  Vincent P, Maskos U, Charvet I, Bourgeais L, Stoppini L, Leresche N, Changeux JP, Lambert R, Meda P, Paupardin-Tritsch D, Live imaging of neural structure and function by fibred fluorescence microscopy, EMBO Rep. 2006 Nov;7(11):1154-61.
• 2006
  Mameli-Engvall M, Evrard A, Pons S, Maskos U, Svensson TH, Changeux JP, Faure P, Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors, Neuron 2006 Jun;50(6):911-21.
• 2006
  Molles BE, Maskos U, Pons S, Besson M, Guiard P, Guilloux JP, Evrard A, Cormier A, Mameli-Engvall M, Cloëz-Tayarani I, Nakatani H, Dufour N, Bemelmans AP, Mallet J, Cazala P, Gardier AM, David V, Faure P, Granon S, Changeux JP, Targeted in vivo expression of nicotinic acetylcholine receptors in mouse brain using lentiviral expression vectors, J. Mol. Neurosci. 2006;30(1-2):105-6.
• 2005
  Mrsic-Flogel TD, Hofer SB, Creutzfeldt C, Cloëz-Tayarani I, Changeux JP, Bonhoeffer T, Hübener M, Altered map of visual space in the superior colliculus of mice lacking early retinal waves, J. Neurosci. 2005 Jul;25(29):6921-8.
• 2005
  Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP, Evrard A, Cazala P, Cormier A, Mameli-Engvall M, Dufour N, Cloëz-Tayarani I, Bemelmans AP, Mallet J, Gardier AM, David V, Faure P, Granon S, Changeux JP, Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors, Nature 2005 Jul;436(7047):103-7.
• 2004
  Cloëz-Tayarani I, Kayyali US, Fanburg BL, Cavaillon JM, 5-HT activates ERK MAP kinase in cultured-human peripheral blood mononuclear cells via 5-HT1A receptors, Life Sci. 2004 Dec;76(4):429-43.
• 2003
  Maskos U, McKay RD, Neural cells without functional N-Methyl-D-Aspartate (NMDA) receptors contribute extensively to normal postnatal brain development in efficiently generated chimaeric NMDA R1 -/- +/+ mice, Dev. Biol. 2003 Oct;262(1):119-36.
• 2003
  Cloëz-Tayarani I, Petit-Bertron AF, Venters HD, Cavaillon JM, Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors, Int. Immunol. 2003 Feb;15(2):233-40.
• 2002
  Maskos U, Kissa K, St Cloment C, Brûlet P, Retrograde trans-synaptic transfer of green fluorescent protein allows the genetic mapping of neuronal circuits in transgenic mice, Proc. Natl. Acad. Sci. U.S.A. 2002 Jul;99(15):10120-5.
• 2001
  Maskos U, Brüstle O, McKay RD, Long-term survival, migration, and differentiation of neural cells without functional NMDA receptors in vivo, Dev. Biol. 2001 Mar;231(1):103-12.
• 2001
  Cavaillon JM, Adib-Conquy M, Cloëz-Tayarani I, Fitting C, Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review, J. Endotoxin Res. 2001;7(2):85-93.
• 1999
  Sarhan H, Cloëz-Tayarani I, Massot O, Fillion MP, Fillion G, 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes, Naunyn Schmiedebergs Arch. Pharmacol. 1999 Jan;359(1):40-7.
• 1998
  Massot O, Rousselle JC, Grimaldi B, Cloëz-Tayarani I, Fillion MP, Plantefol M, Bonnin A, Prudhomme N, Fillion G, Molecular, cellular and physiological characteristics of 5-HT-moduline, a novel endogenous modulator of 5-HT1B receptor subtype, Ann. N. Y. Acad. Sci. 1998 Dec;861:174-82.
• 1998
  Cloëz-Tayarani I, Cardona A, Sarhan H, Rousselle JC, Massot O, Edelman L, Fillion G, Mapping of 5-HT-moduline binding sites in guinea-pig brain by film and digital autoradiography, Brain Res. 1998 Jul;798(1-2):311-5.
• 1997
  Cloëz-Tayarani I, Cardona A, Rousselle JC, Massot O, Edelman L, Fillion G, Autoradiographic characterization of [3H]-5-HT-moduline binding sites in rodent brain and their relationship to 5-HT1B receptors, Proc. Natl. Acad. Sci. U.S.A. 1997 Sep;94(18):9899-904.
• 1997
  Cloëz-Tayarani I, Fillion G, The in situ hybridization and immunocytochemistry techniques for characterization of cells expressing specific mRNAs in paraffin-embedded brains, Brain Res. Brain Res. Protoc. 1997 May;1(2):195-202.
• 1996
  Massot O, Rousselle JC, Fillion MP, Grimaldi B, Cloëz-Tayarani I, Fugelli A, Prudhomme N, Seguin L, Rousseau B, Plantefol M, Hen R, Fillion G, 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors, Mol. Pharmacol. 1996 Oct;50(4):752-62.
• 1996
  Cloëz-Tayarani I, Wusher N, Huerre M, Fillion G, Cellular localization of 5-HT1B receptor mRNA in the rat olfactory tubercle: do GABAergic neurons express the 5-HT1B gene?, Brain Res. Mol. Brain Res. 1996 Mar;36(2):337-42.
• 1995
  Bolanos-Jimenez F, Manhaes de Castro RM, Seguin L, Cloez-Tayarani I, Monneret V, Drieu K, Fillion G, Effects of stress on the functional properties of pre- and postsynaptic 5-HT1B receptors in the rat brain, Eur. J. Pharmacol. 1995 Dec;294(2-3):531-40.
• 1995
  Grimaldi B, Cloez-Tayarani I, Fillion MP, Mazie JC, Hen R, Fillion G, Production and characterization of an antibody directed against the mouse 5HT1B receptor, Neurosci. Res. 1995 Dec;24(1):97-101.
• 1995
  Brüstle O, Maskos U, McKay RD, Host-guided migration allows targeted introduction of neurons into the embryonic brain, Neuron 1995 Dec;15(6):1275-85.
• 1994
  Southern EM, Maskos U, Parallel synthesis and analysis of large numbers of related chemical compounds: applications to oligonucleotides, J. Biotechnol. 1994 Jun;35(2-3):217-27.
• 1993
  Maskos U, Southern EM, A study of oligonucleotide reassociation using large arrays of oligonucleotides synthesised on a glass support, Nucleic Acids Res. 1993 Oct;21(20):4663-9.
• 1993
  Maskos U, Southern EM, A novel method for the analysis of multiple sequence variants by hybridisation to oligonucleotides, Nucleic Acids Res. 1993 May;21(9):2267-8.
• 1993
  Maskos U, Southern EM, A novel method for the parallel analysis of multiple mutations in multiple samples, Nucleic Acids Res. 1993 May;21(9):2269-70.
• 1993
  Cloëz-Tayarani I, Fillion G, [Fundamental aspects of molecular biology. The multigene family of 5-HT1 receptors], Encephale 1993 May-Jun;19(3):215-9.
• 1993
  Simon-Chazottes D, Cloez-Tayarani I, Fillion MP, Guénet JL, Fillion G, The serotonin 5-HT1B receptor subtype (Htr1b) gene maps to mouse chromosome 9, Mamm. Genome 1993;4(7):397-8.
• 1992
  Southern EM, Maskos U, Elder JK, Analyzing and comparing nucleic acid sequences by hybridization to arrays of oligonucleotides: evaluation using experimental models, Genomics 1992 Aug;13(4):1008-17.
• 1992
  Maskos U, Southern EM, Parallel analysis of oligodeoxyribonucleotide (oligonucleotide) interactions. I. Analysis of factors influencing oligonucleotide duplex formation, Nucleic Acids Res. 1992 Apr;20(7):1675-8.
• 1992
  Maskos U, Southern EM, Oligonucleotide hybridizations on glass supports: a novel linker for oligonucleotide synthesis and hybridization properties of oligonucleotides synthesised in situ, Nucleic Acids Res. 1992 Apr;20(7):1679-84.
• 1992
  Weydert A, Cloez-Tayarani I, Fillion MP, Simon-Chazottes D, Guenet JL, Fillion G, Molecular cloning of two partial serotonin 5-HT1D receptor sequences in mouse and one in guinea pig, C. R. Acad. Sci. III, Sci. Vie 1992;314(10):429-35.
• 1992
  Cloëz-Tayarani I, Harel-Dupas C, Fillion G, Inhibition of [3H] gamma-aminobutyric acid release from guinea-pig hippocampal synaptosomes by serotonergic agents, Fundam Clin Pharmacol 1992;6(8-9):333-41.